Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2016Vol. 62 Suppl 2pp. -
691
g2016clinicalimpact
Abstract
Results from the first 3 years following RV1 introduction suggest substantial reductions of pediatric diarrheal disease as a result of vaccination. Our VE estimate is consistent with the observed rotavirus decrease and with efficacy estimates from elsewhere in sub-Saharan Africa.